143516-86-3

Basic information

• Product Name: Benzene, 1-[diphenyl[[4-(phenylmethoxy)-2-butenyl]oxy]methyl]-4-methoxy-, (E)-
• CAS NO: 143516-86-3
• Molecular Formula: C31H30O3
• Molecular Weight: 450.577
• Mol File: 143516-86-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzene, 1-[diphenyl[[4-(phenylmethoxy)-2-butenyl]oxy]methyl]-4-methoxy-, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-[diphenyl[[4-(phenylmethoxy)-2-butenyl]oxy]methyl]-4-methoxy-, (E)-(143516-86-3)
• EPA Substance Registry System: Benzene, 1-[diphenyl[[4-(phenylmethoxy)-2-butenyl]oxy]methyl]-4-methoxy-, (E)-(143516-86-3)

Safety Data

• Hazardous Substances Data: 143516-86-3(Hazardous Substances Data)

Upstream product

• 143516-84-1 Propionic acid (E)-4-[(4-methoxy-phenyl)-diphenyl-methoxy]-but-2-enyl ester 
• 143516-84-1 Propionic acid (Z)-4-[(4-methoxy-phenyl)-diphenyl-methoxy]-but-2-enyl ester 
• 100-39-0 benzyl bromide 
• 122885-62-5 4'-methoxytrityl-4-oxy-buten-2-en-1-ol 

Downstream Products

• 78513-15-2 <2R-(2β,3α)>-3-<(phenylmethoxy)methyl>oxiranemethanol 
• 78469-85-9 (2S,3S)-4-benzyloxy-2,3-epoxy-1-butanol 
• 78513-07-2 ((2R,3S)-3-((benzyloxy)methyl)oxiran-2-yl)methanol 
• 78513-07-2 (-)-(2S,3R)-2,3-epoxy-4-(benzyloxy)-1-butanol 
• 80885-30-9 (E)-4-(benzyloxy)-2-buten-1-ol 
• 81028-03-7 (Z)-4-benzyloxy-but-2-en-1-ol 

Relevant articles and documents

Syntheses of two pairs of enantiomeric C18-sphingosines and a palmitoyl analogue of gaucher spleen glucocerebroside

Sixteen kinds of chiral C4-epoxides [(-)-10a-d,(+)-10a-d,(-)-11a-d,(+)-11a-d], which are synthons in our synthetic strategy for complex lipids, have been prepared from (2Z)-2-butene-1,4-diol (6) by employing a Sharpless asymmetric epoxidation. By using the chiral C4-epoxides [(+)-10a,(-)-10a,(-)-11a,(+)-11a] as starting compounds, two pairs of enantiomeric (D-erythro, L-erythro, D-threo, and L-threo)-C18-sphingosines (1, 2, 3, 4) have been synthesized via a regioselective ring-opening of the epoxide ring with azide anion followed by reduction of the azide group to an amino group and a Wittig reaction. Furthermore, D-erythro-C18-sphingosine (1) has been converted to a palmitoyl analogue (5a) of Gaucher spleen glucocerebroside (5) through a reaction pathway including successive condensations with palmitic acid and D-glucose.